Found: 5
Select item for more details and to access through your institution.
A randomized phase 1/2a trial of ExPEC10V vaccine in adults with a history of UTI.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00885-1
- By:
- Publication type:
- Article
Tuberculosis following PD-1 blockade for cancer immunotherapy.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 475, p. N.PAG, doi. 10.1126/scitranslmed.aat2702
- By:
- Publication type:
- Article
The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0057-5
- By:
- Publication type:
- Article
Impact of inducible co-stimulatory molecule (ICOS) on T-cell responses and protection against Mycobacterium tuberculosis infection.
- Published in:
- European Journal of Immunology, 2011, v. 41, n. 4, p. 981, doi. 10.1002/eji.201040608
- By:
- Publication type:
- Article
Secondary lymphoid organs are dispensable for the development of T-cell-mediated immunity during tuberculosis.
- Published in:
- European Journal of Immunology, 2010, v. 40, n. 6, p. 1663, doi. 10.1002/eji.201040299
- By:
- Publication type:
- Article